SCHEMBL17640438

SCHEMBL17640438

CC1(C)c2ccccc2N(c2ccc(-c3nsc(-c4ccc(F)cc4)n3)cc2)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 3/20 0.40
▸ PGR P06401 1/20 0.38
▸ MAPT P10636 7/20 0.38
▸ HTT P42858 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ HSD17B1 P14061 2/20 0.34
▸ HSD17B2 P37059 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ ALPG P10696 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ FAAH O00519 2/20 0.33
▸ SNCA P37840 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ TP53 P04637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19499753 0.94 CYP19A1 (0.44) CYP19A1MAPTNPC1SMN1; SMN2RAB9A
SCHEMBL17640551 0.92 CYP19A1 (0.42) CYP19A1MAPTHTTNPC1SMN1; SMN2
SCHEMBL17640613 0.92 CYP19A1 (0.42) CYP19A1MAPTHTTNPC1SMN1; SMN2
SCHEMBL19499757 0.89 CYP19A1 (0.40) CYP19A1PGRMAPTNPC1SMN1; SMN2
SCHEMBL17640624 0.87 CYP19A1 (0.39) CYP19A1MAPTHSD17B1HSD17B2SNCA
SCHEMBL21915236 0.86 CYP19A1 (0.38) CYP19A1MAPTNPC1SMN1; SMN2RAB9A
SCHEMBL21915621 0.84 CYP19A1 (0.36) CYP19A1MAPTHSD17B1HSD17B2ALDH1A1
SCHEMBL21915246 0.84 HSD17B1 (0.43) CYP19A1MAPTHSD17B1HSD17B2SNCA
SCHEMBL21915460 0.84 HSD17B1 (0.41) CYP19A1MAPTNPC1SMN1; SMN2RAB9A
SCHEMBL21915197 0.83 HSD17B1 (0.38) CYP19A1PGRMAPTHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency UDC IRELAND LIMITED (IE) 2019-06-25 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
WO-2016046350-A1 FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY BASF SE (DE) 2016-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency NR2E3, CRY1, ALDH1A2 CYP19A1 2245/4885PGR 4526/4885MAPT 2708/4885
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency NR2E3, CRY1, ALDH1A2 CYP19A1 2245/4885PGR 4526/4885MAPT 2708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback